Cyclophane and acyclic cyclophane: Novel channel blockers of N-methyl-d-aspartate receptor

Neurochemistry International

Volumn 50, Issue 2, 2007, Pages 443-449

  Masuko, Takashi ^a   Nagaoka, Hiroki ^a   Miyake, Muneharu ^a   Metori, Koichi ^a   Kizawa, Yasuo ^a   Kashiwagi, Keiko ^b   Igarashi, Kazuei ^c   Kusama, Tadashi ^a  

^a NIHON UNIVERSITY   (Japan)

^b CHIBA INSTITUTE OF SCIENCE   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Acyclic cyclophane; Cyclophane; Ligand gated ion channels; N Methyl d aspartate receptor; Open channel blockers; Voltage clamp recording; Xenopus oocytes

Indexed keywords

ACYCLIC CYCLOPHANE; AMINO ACID; AMPA RECEPTOR; ASPARAGINE; CALCIUM; CHLORIDE; CYCLOPHANE; CYCLOPHANE DERIVATIVE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; ION CHANNEL; MAGNESIUM; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 1ALPHA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2; N,N' (6H,12H 5,11 METHANODIBENZO[B,F][1,5]DIAZOCINE 2,8 DIYLDI 2,1 ETHANEDIYL)BIS[N [3 (4 DIMETHYLAMINOPYRIDINIUM)PROPYL]PHENETHYLAMINE]DICHLORIDE; N,N' BIS(1,4,7,10 TETRAAZACYCLODODECAN 1 YLACETYL) 10,26 DIAZA 7,13,23,29 TETRAOXA[7.1.7.1]PARACYCLOPHANE; N,N' BIS[3 (4 DIMETHYLAMINOPYRIDINIUM)PROPYL] 10,26 DIAZA 7,13,23,29 TETRAOXA[7.1.7.1]PARACYCLOPHANE DICHLORIDE; PARACYCLOPHANE DERIVATIVE; PHENETHYLAMINE DERIVATIVE; PYRIDINIUM DERIVATIVE; PYRIMIDINONE DERIVATIVE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FEMALE; IC 50; MEMBRANE CURRENT; MEMBRANE STEADY POTENTIAL; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; VOLTAGE CLAMP; XENOPUS;

ANIMALS; AZOCINES; CELL DEATH; CLONING, MOLECULAR; CROWN COMPOUNDS; ELECTROPHYSIOLOGY; ETHERS, CYCLIC; NEURONS; OOCYTES; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PYRIDINES; RECEPTORS, AMPA; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; XENOPUS LAEVIS;

EID: 33846263697     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.10.003     Document Type: Article

References (35)

1. Beck C., Wollmuth L.P., Seeburg P.H., Sakmann B., and Kuner T. NMDAR channel segments forming the extracellular vestibule inferred from the accessibility of substituted cysteines. Neuron 22 (1999) 559-570
2. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 356 (1992) 521-523
3. Collingridge G.L., and Lester R.A.J. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 41 (1989) 143-210
4. Collingridge G.L., and Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol. Sci. 11 (1990) 290-296
5. Danysz W., Zajaczkowski W., and Parsons C.G. Modulation of learning processes by ionotropic glutamate receptor ligands. Behav. Pharmacol. 6 (1995) 455-474
6. Danysz W., and Parsons C.G. Glycine and N-methyl-d-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol. Rev. 50 (1998) 597-664
7. Dingledine R., Borges K., Bowie D., and Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51 (1999) 7-61
8. Greene J.G., and Greenamyre J.T. Bioenergetics and glutamate excitotoxicity. Prog. Neurobiol. 48 (1996) 613-634
9. Huettner J.E., and Bean B.P. Block of N-methyl-d-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 1307-1311
10. Igarashi K., Shirahata A., Pahk A.J., Kashiwagi K., and Williams K. Benzyl-polyamines: novel, potent N-methyl-d-aspartate receptor antagonists. J. Pharmacol. Exp. Ther. 283 (1997) 533-540
11. Ikeda K., Nagasawa M., Mori H., Araki K., Sakimura K., Watanabe M., Inoue Y., and Mishina M. Cloning and expression of the ε4 subunit of the NMDA receptor channel. FEBS Lett. 313 (1992) 34-38
12. Jerchel D., Fischer H., and Thomas K. Syntheses with pyridylpyridinium halides. Introduction of halogens of the thiol and thiol ether group into the 4-position of the pyridine ring. Chem. Ber. 89 (1956) 2921-2933
13. Kashiwagi K., Pahk A.J., Masuko T., Igarashi K., and Williams K. Block and modulation of N-methyl-d-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits. Mol. Pharmacol. 52 (1997) 701-713
14. Kashiwagi K., Masuko T., Nguyen C.D., Kuno T., Tanaka I., Igarashi K., and Williams K. Channel blockers acting at N-methyl-d-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore. Mol. Pharmacol. 61 (2002) 533-545
15. Kashiwagi K., Tanaka I., Tamura M., Sugiyama H., Okawara T., Otsuka M., Sabado T.N., Williams K., and Igarashi K. Anthraquinone polyamines: novel channel blockers to study N-methyl-d-aspartate receptors. J. Pharmacol. Exp. Ther. 309 (2004) 884-893
16. Kuner T., Wollmuth L.P., Karlin A., Seeburg P.H., and Sakmann B. Structure of the NMDA receptor channel M2 segment inferred from the accessibility of substituted cysteines. Neuron 17 (1996) 343-352
17. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K., Meguro H., Masaki H., Kumanishi T., Arakawa M., and Mishina M. Molecular diversity of the NMDA receptor channel. Nature 358 (1992) 36-41
18. Leonard J.P., and Kelso S.R. Apparent desensitization of NMDA responses in Xenopus oocytes involves calcium-dependent chloride current. Neuron 4 (1990) 53-60
19. Masu M., Tanabe Y., Tsuchida K., Shigemoto R., and Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature 349 (1991) 760-765
20. Masuko T., Kuno T., Kashiwagi K., Kusama T., Williams K., and Igarashi K. Stimulatory and inhibitory properties of aminoglycoside antibiotics at N-methyl-d-aspartate receptors. J. Pharmacol. Exp. Ther. 290 (1999) 1026-1033
21. Masuko T., Kashiwagi K., Kuno T., Nguyen N.D., Pahk A.J., Fukuchi J., Igarashi K., and Williams K. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-d-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. Mol. Pharmacol. 55 (1999) 957-969
22. Masuko T., Suzuki I., Kizawa Y., Kusama-Eguchi K., Watanabe K., Kashiwagi K., Igarashi K., and Kusama T. Monoamines directly inhibit N-methyl-d-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner. Neurosci. Lett. 371 (2004) 30-33
23. Masuko T., Metori K., Kizawa Y., Kusama T., and Miyake M. Design and synthesis of a novel water-soluble NMDA receptor antagonist with a 1,4,7,10-tetraazacyclododecane group. Chem. Pharm. Bull. 53 (2005) 444-447
24. Metori K., and Miyake M. Design and synthesis of a novel cyclophane as host for biologically relevant phosphates. Heterocycles 60 (2003) 1441-1445
25. Metori K., Sei Y., Kimura Y., Ozawa T., Yamaguchi K., and Miyake M. Measurement of inclusion complex formation between cyclophane and biological relevant amino acids using electrospray ionization, cold-spray ionization and fast atom bombardment mass spectrometry. Chem. Pharm. Bull. 53 (2005) 1029-1033
26. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., and Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256 (1992) 1217-1221
27. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., and Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 354 (1991) 31-37
28. Nahum-Levy R., Fossom L.H., Skolnick P., and Benveniste M. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-d-aspartate receptors. Mol. Pharmacol. 56 (1999) 1207-1218
29. 2+ ions to repeated stimulation by N-methyl-d-aspartate in cultured rat cortical neurons. Neurochem. Int. 49 (2006) 230-237
30. Paoletti P., Perin-Dureau F., Fayyazuddin A., Le Goff A., Callebaut I., and Neyton J. Molecular organization of a zinc binding N-terminal modulatory domain in a NMDA receptor subunit. Neuron 28 (2000) 911-925
31. Parsons C.G., Danysz W., and Quack G. Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist-a review of preclinical data. Neuropharmacology 38 (1999) 735-767
32. Sakimura K., Bujo H., Kushiya E., Araki K., Yamazaki M., Yamazaki M., Meguro H., Warashina A., Numa S., and Mishina M. Functional expression from cloned cDNAs of glutamate receptor species responsive to kainate and quisqualate. FEBS Lett. 272 (1990) 73-80
33. Sanganahalli G.B., Joshi G.P., and Joshi B.N. NMDA and non-NMDA receptors stimulation causes differential oxidative stress in rat cortical slices. Neurochem. Int. 49 (2006) 475-480
34. Steffens M., Huppertz J.-H., Zentner J., Chauzit E., and Feuerstein J.T. Unchanged glutamine synthetase activity and increased NMDA receptor density in epileptic human neocortex: implications for the pathophysiology of epilepsy. Neurochem. Int. 47 (2005) 379-384
35. 2+. Mol. Pharmacol. 53 (1998) 933-941